Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$9.45

0.27 (2.94%)

08:10
12/02/19
12/02
08:10
12/02/19
08:10

Puma Biotechnology amends license agreement with Pierre Fabre

Puma Biotechnology and Pierre Fabre have agreed to extend the terms of the license agreement in which Puma granted Pierre Fabre exclusive rights to develop and commercialize NERLYNX within Europe and part of Africa. The amended agreement extends Pierre Fabre's commercial rights for NERLYNX to the Middle East, South Africa, Sudan and Turkey. Under the terms of the agreement, Puma will receive an upfront payment of $4M, as well as additional regulatory and sales-based milestone payments totaling up to $3M. Net sales of NERLYNX from the countries in this extension territory will be included in the calculation of payments related to sales milestones and royalties from the original license agreement signed earlier this year.

PBYI Puma Biotechnology
$9.45

0.27 (2.94%)

10/21/19
GSCO
10/21/19
NO CHANGE
GSCO
Sell
Goldman says Seattle Genetics' positive results affirm narrower Puma opportunity
Goldman Sachs analyst Paul Choi said Seattle Genetics' (SGEN) positive top-line results from its HER2CLIMB trial of tucatinib in HER2+ breast cancer patients likely affirm a narrower metastatic opportunity for Puma Biotechnology's (PBYI) Nerlynx. Nerlynx will have a first-mover advantage, acknowledges Choi, but he continues to expect low market penetration based on its side effects and lack of an OS benefit, leading him to maintain a Sell rating on Puma shares.
11/07/19
LEHM
11/07/19
NO CHANGE
Target $6
LEHM
Underweight
Puma Biotechnology price target lowered to $6 from $9 at Barclays
Barclays analyst Gena Wang lowered her price target for Puma Biotechnology to $6 from $9 and keeps an Underweight rating on the shares. Puma reported Q3 Nerlynx revenue of $53.6M, below the consensus of $59.0M, and lowered its 2019 guidance for the second time to $205M-$210M from $220M-$240M, Wang tells investors in a research note. The analyst continues to see a limited growth outlook in extended adjuvant setting as well as metastatic HER2+ breast cancer.
11/07/19
RBCM
11/07/19
NO CHANGE
Target $13
RBCM
Sector Perform
Puma Biotechnology price target lowered to $13 from $23 at RBC Capital
RBC Capital analyst Kennen MacKay lowered his price target on Puma Biotechnology to $13 and kept his Sector Perform rating after its Q3 results showed a miss on Nerlynx sales. The analyst warns that the print may reflect lower demand due to dose-reductions, also noting his lowered estimates in late-stage metastatic breast cancer where he sees greater competitive pressure from other HER2+ agents in that setting.
11/08/19
CANT
11/08/19
NO CHANGE
Target $14
CANT
Neutral
Puma Biotechnology price target lowered to $14 from $20 at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young lowered her price target for Puma Biotechnology to $14 from $20 saying she's more cautious on the long-term revenue outlook for Nerlynx following the company's Q3 results. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

ASMI

ASM International

$0.00

(0.00%)

06:48
12/12/19
12/12
06:48
12/12/19
06:48
Conference/Events
ASM International management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$88.96

-0.12 (-0.13%)

06:47
12/12/19
12/12
06:47
12/12/19
06:47
Hot Stocks
Merck: KEYTRUDA showed improvements in OS in Phase 3 KEYNOTE-042 trial »

Merck announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

CG

Carlyle Group

$30.19

0.69 (2.34%)

, APO

Apollo Global

$44.97

0.67 (1.51%)

06:47
12/12/19
12/12
06:47
12/12/19
06:47
Downgrade
Carlyle Group, Apollo Global, Ares Management rating change  »

Carlyle Group downgraded…

CG

Carlyle Group

$30.19

0.69 (2.34%)

APO

Apollo Global

$44.97

0.67 (1.51%)

ARES

Ares Management

$33.56

0.01 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

JCI

Johnson Controls

$42.71

0.62 (1.47%)

06:47
12/12/19
12/12
06:47
12/12/19
06:47
Initiation
Johnson Controls initiated  »

Johnson Controls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APO

Apollo Global

$44.97

0.67 (1.51%)

06:46
12/12/19
12/12
06:46
12/12/19
06:46
Downgrade
Apollo Global rating change  »

Apollo Global downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

FDX

FedEx

$159.05

2.07 (1.32%)

06:44
12/12/19
12/12
06:44
12/12/19
06:44
Upgrade
FedEx rating change  »

FedEx upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

IR

Ingersoll-Rand

$132.95

1.77 (1.35%)

06:42
12/12/19
12/12
06:42
12/12/19
06:42
Initiation
Ingersoll-Rand initiated  »

Ingersoll-Rand initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASMB

Assembly Biosciences

$17.75

0.15 (0.85%)

06:42
12/12/19
12/12
06:42
12/12/19
06:42
Syndicate
Assembly Biosciences 5.152M share Spot Secondary priced at $16.50 »

Jefferies and SVB Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

LL

Lumber Liquidators

$9.49

-0.04 (-0.42%)

06:41
12/12/19
12/12
06:41
12/12/19
06:41
Earnings
Lumber Liquidators backs FY19 revenue growth view of flat to slightly positive »

Consensus $1.09B. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

$30.41

1.05 (3.58%)

06:41
12/12/19
12/12
06:41
12/12/19
06:41
Initiation
II-VI initiated  »

II-VI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$69.87

0.97 (1.41%)

06:40
12/12/19
12/12
06:40
12/12/19
06:40
Initiation
Lumentum initiated  »

Lumentum initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$176.09

2.1 (1.21%)

06:39
12/12/19
12/12
06:39
12/12/19
06:39
Initiation
Honeywell initiated  »

Honeywell initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$211.96

-3.88 (-1.80%)

06:39
12/12/19
12/12
06:39
12/12/19
06:39
Downgrade
Home Depot rating change  »

With 'mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ETN

Eaton

$93.38

0.69 (0.74%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Initiation
Eaton initiated  »

Eaton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$54.03

-0.15 (-0.28%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Conference/Events
Western Alliance management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$191.07

2.43 (1.29%)

06:34
12/12/19
12/12
06:34
12/12/19
06:34
Conference/Events
Norfolk Southern management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EMR

Emerson

$75.75

1.21 (1.62%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Initiation
Emerson initiated  »

Emerson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$2.47

0.17 (7.39%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Earnings
Veru reports Q4 EPS (5c), consensus (5c) »

Reports Q4 revenue $8.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TRKNY

Turk Telekom

$0.00

(0.00%)

06:31
12/12/19
12/12
06:31
12/12/19
06:31
Downgrade
Turk Telekom rating change  »

Turk Telekom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$0.00

(0.00%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Upgrade
AkzoNobel rating change  »

AkzoNobel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.45

1.51 (2.96%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Initiation
Cognex initiated  »

Cognex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

, INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

06:29
12/12/19
12/12
06:29
12/12/19
06:29
Recommendations
Americold Realty Trust, Invitation Homes analyst commentary  »

Citi adds Americold…

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSG

Wanda Sports

$2.82

-0.01 (-0.35%)

06:28
12/12/19
12/12
06:28
12/12/19
06:28
Downgrade
Wanda Sports rating change  »

Wanda Sports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

, SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change  »

SeaSpine, Glaukos…

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

MMSI

Merit Medical

$29.99

0.69 (2.35%)

MDT

Medtronic

$111.67

0.62 (0.56%)

TFX

Teleflex

$354.93

1.18 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.